Editorial
Accepted on 02 Jan 2025
Editorial: Two Decades of Targeted Therapies in Hematology -New Targets and Novel Combinations
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2025.1548984
Type at least 3 characters
14 articles
Articles
Original Research
Published on 26 Dec 2024
Unique target binding by the C-terminal region of FHR1 provides a new perception of aHUS pathology
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2024.1469176
- 411 views
Brief Research Report
Published on 17 Jun 2024
Novel cryopreservation medium for enhanced stability of T cells at −80°C
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2024.1346627
- 956 views
- 1 citation
Review
Published on 08 Mar 2024
Management of secondary immunodeficiency in hematological malignancies: a Delphi consensus from the Middle East
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2024.1347708
- 1,828 views
Clinical Trial
Published on 09 Nov 2023
4SCAR2.0 therapy for the management of post-transplantation relapse of B-cell acute lymphoblastic leukemia
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2023.1251622
- 694 views
Original Research
Published on 25 Aug 2023
Drug exporter expression correlates with group 3 innate lymphoid cell resistance to immunosuppressive agents
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2023.1144418
- 642 views
Review
Published on 10 Aug 2023
The link between immune thrombocytopenia and the cytokine profile: a bridge to new therapeutical targets
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2023.1191178
- 3,126 views
- 7 citations
Review
Published on 03 Aug 2023
Abatacept and T-cell costimulation blockade—shifting the paradigm in the prevention of graft-versus-host disease
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2023.1243247
- 1,646 views
- 1 citation
Case Report
Published on 15 May 2023
Case Report: Thrombopoietin receptor agonists in resistant thrombocytopenia in pregnancy: a case series and review of literature
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2023.1180156
- 2,029 views
- 1 citation
Original Research
Published on 10 May 2023
Post CAR T-cell therapy outcomes and management in HSCT-naive patients: a single-center experience
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2023.1151744
- 1,309 views
- 1 citation
Original Research
Published on 07 Mar 2023
Identification factors to adjust early combination regimens in adult primary immune thrombocytopenia: An 8-year data analysis
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2023.1135261
- 1,169 views
Case Report
Published on 19 Dec 2022
Case Report: A unique case of secondary hemophagocytic lymphohistiocytosis from ehrlichiosis infection
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2022.1039821
- 2,170 views
Case Report
Published on 14 Nov 2022
Immunophenotypic transformation in relapsed/refractory mantle cell lymphoma treated with human anti-CD5 chimeric antigen receptor T cells: A Case Report
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2022.967156
- 852 views
- 1 citation
Original Research
Published on 03 Nov 2022
Recombinant factor VIII Fc fusion protein engages monocytes via Fc and FVIII domains to reduce monocyte differentiation into osteoclasts
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2022.1020852
- 1,583 views
- 1 citation